 |
|
Provision of Methadone Treatment in Primary Care Medical Practices
Review of the Scottish Experience and Implications for US Policy
Michael Weinrich, MD;
Mary Stuart, ScD
JAMA. 2000;283:1343-1348.
Context Under new proposed regulations, US physicians outside of traditional methadone clinics could prescribe methadone to patients with opioid dependence. No large-scale evaluations of US programs in which methadone maintenance is provided by primary care physicians are available, but primary care physicians in Scotland have participated in such programs on a large scale.
Objective To review the history, operation, and outcome data on the efficacy and safety of 2 Scottish primary care–based opioid agonist treatment programs to derive lessons for the US context.
Design and Setting Naturalistic study of programs in Edinburgh and Glasgow, Scotland, with data obtained through site visits and interviews conducted in 1996 and 1998, as well as from published reports and retrospective analysis of electronic databases.
Main Outcome Measures Proportions of injection drug users who were enrolled in the methadone maintenance programs, average methadone doses in the programs, and methadone-related deaths.
Results A total of 60% to 80% of injection drug users in Edinburgh and 41% to 73% of those in Glasgow were enrolled in methadone maintenance in 1998-1999. Dose levels are consistent with US recommendations (for Edinburgh in 1998, 61 mg; for Glasgow in 1994-1996, 54 mg). The Glasgow program required supervised consumption of methadone in community pharmacies for the first year and experienced significantly fewer methadone-related deaths than Edinburgh in 1997 (17 vs 30 deaths; P<.0001). Programs in both Edinburgh and Glasgow provided support to primary care physicians and achieved levels of general practitioner participation of 59% (1998) and 30% (1999), respectively.
Conclusions The Scottish experience indicates that prescription of methadone in office-based settings can expand access to an important treatment modality. Primary care physicians safely prescribed methadone for maintenance treatment when provided with adequate support. Diversion of methadone was minimized by requiring supervised consumption in community pharmacies.
Author Affiliations: Department of Neurology, University of Maryland, Baltimore (Dr Weinrich) and Department of Sociology and Anthropology, University of Maryland Baltimore County (Dr Stuart). Dr Weinrich is now with the National Center for Medical Rehabilitation Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md.
RELATED ARTICLES
Methadone Maintenance vs 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial
Karen L. Sees, Kevin L. Delucchi, Carmen Masson, Amy Rosen, H. Westley Clark, Helen Robillard, Peter Banys, and Sharon M. Hall
JAMA. 2000;283(10):1303-1310.
ABSTRACT
| FULL TEXT
Treatment for Opioid Dependence: Quality and Access
Bruce J. Rounsaville and Thomas R. Kosten
JAMA. 2000;283(10):1337-1339.
EXTRACT
| FULL TEXT
Treating Drug Dependency
JAMA. 2000;283(10):1378.
PDF
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Barriers and Facilitators to Primary Care or Human Immunodeficiency Virus Clinics Providing Methadone or Buprenorphine for the Management of Opioid Dependence
Turner et al.
Arch Intern Med 2005;165:1769-1776.
ABSTRACT
| FULL TEXT
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT
| FULL TEXT
Integrated Health System for Chronic Disease Management: Lessons Learned From France
Stuart and Weinrich
Chest 2004;125:695-703.
ABSTRACT
| FULL TEXT
New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence
Fiellin and O'Connor
ANN INTERN MED 2002;137:688-692.
ABSTRACT
| FULL TEXT
Methadone Maintenance in Primary Care: A Randomized Controlled Trial
Fiellin et al.
JAMA 2001;286:1724-1731.
ABSTRACT
| FULL TEXT
Methadone Maintenance: Is It Our Best Alternative?
JWatch Psychiatry 2000;2000:9-9.
FULL TEXT
Treatment for Opioid Dependence: Quality and Access
Rounsaville and Kosten
JAMA 2000;283:1337-1339.
FULL TEXT
|
